Author Question: Describe a motivational process model. According to research on middle childhood, discuss how ... (Read 72 times)

yoroshambo

  • Hero Member
  • *****
  • Posts: 566
Describe a motivational process model. According to research on middle childhood, discuss how children view their abilities and explain why they are more vulnerable to evaluations by others. What allows some people to persevere after a failed attempt? How does their confidence influence their achievement behavior?
 
  What will be an ideal response?

Question 2

When compared to school-age females, males tend to rate themselves higher in:
 
  a. Math and sports
  b. Reading and social studies
  c. English and science
  d. All of the above



FergA

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

Answers must include the different achievement outcomes between ability seen as stable to internal and external forces as well as a comparison of ability as capacity or as a fixed trait.

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library